Items Tagged ‘Lung Cancer’
February 3, 2022
Lung cancer: It is about more than smoking
By Susan Murphy 
By Sharon Theimer World Cancer Day is February 4 and that makes this the ideal time to talk about lung cancer and smoking. Internationally, lung cancer is the most common cause of cancer deaths and the World Health Organization estimates that 90% of cases could be prevented by eliminating tobacco use. People who smoke are at the greatest risk. Smokeless tobacco is also associated […]
May 29, 2019
By Sharon Rosen 
Amidst the demands of providing care for patients with cancer, it can be challenging for oncologists and their care teams to keep up with the rapidly evolving field of genomics. Practical ways to apply the latest precision medicine discoveries is the focus of this year’s Individualizing Medicine Conference: Precision Cancer Care through Immunotherapy and Genomics, […]
Tags: #CAR T-cell therapy, #CIMCon19, biliary cancer, breast cancer, center for individualized medicine, Dr. Alan Bryce, familial cancer syndromes, hematologic cancers, immunotherapies, Individualizing Medicine Conference 2019, Lung Cancer, lymphoma
August 2, 2017
Expanding the search: genetic testing reveals new targets, treatment options for cancer patients
By Sharon Rosen
Researchers in Mayo Clinic Center for Individualized Medicine are using new genetic tests developed at Mayo Clinic to find more effective therapies for cancer patients who have not benefited from standard treatment and are running out of options. The new tests look at a broader range of genetic characteristics than many standard tests. As a […]
Tags: #3-d models, #boimarker, #CIMCon17, #DNA analysis, #Dr. Aaron Mansfield, #Dr. George Vasmatizis, #genetic variations, #liquid biopsies, center for individualized medicine, Genetic Testing, genomics, Lung Cancer
December 9, 2014
Tracing the Lineage of Lung Cancer Tumors
By Center for Individualized Medicine 
A diagnostic test based on chromosomal rearrangements can trace the lineage of lung cancer to determine whether two separate lung cancers in the same patient are independent tumors or a tumor that has spread to another region of the lung, a Mayo Clinic study has found. For patients with multiple tumors, that distinction […]
Tags: biomarkers, cancer, center for individualized medicine, DNA, DNA Sequencing, dna test, DNA Testing, gene sequencing, genetic, Genetics, genome, genome science
June 24, 2014
Effective Methods for Combating Aggressive Forms of Lung Cancer Publication
By AJ Montpetit 
According to a recently published article in the journal Cancer Research, a new study from the Center for Individualized Medicine has found tumor sequencing of several different lung cancers and their surrounding tissue complicates the prevailing theory of linear lung cancer progression and offers new insights for management of this deadly cancer. Sequencing results […]
Tags: cancer, center for individualized medicine, DNA, DNA Sequencing, dna test, DNA Testing, gene sequencing, Genetics, genome, genome science, Genome Sequencing, genomic medicine
December 19, 2013
With lung cancer accounting for more cancer-related deaths each year than the next four leading cancer types combined, the need for earlier diagnosis and better treatment options is clear. Oncospire Genomics, the recently formed joint venture between Cancer Genetics, Inc and Mayo Clinic, aims to shift the tide in lung cancer treatment. The goal of […]
Tags: Biobank, cancer, Cancer Genetics Inc, center for individualized medicine, Follicular lymphoma, Genetics, genomics, Gianrico Farrugia, Lung Cancer, mayo clinic, Multiple Myeloma, next generation sequencing
November 21, 2013
ASCL1 And RET Expression Defines Clinically Relevant Subgroup Of Lung Adenocarcinoma
By Center for Individualized Medicine
A recent publication, featuring the Director of the Biomarker Discovery Program at the Center for Individualized Medicine at Mayo Clinic, George Vasmatzis, examining the role of ASCL1 in the neuroendocrine differentiation of lung adenocarcinoma. The clinical significance of neuroendocrine differentiation in lung adenocarcinoma, and the most appropriate biomarkers for this assessment, has long been debated. In the […]
Tags: ASCL1, biomarker, Biomarker Discovery, Biomarker Discovery Program, cancer, center for individualized medicine, chromogranin, DNA, George Vasmatzis, immunohistochemical, individualized medicine, Lung Cancer
October 17, 2013
Discovering Smoker’s Lung Cancer Biomarker
By AJ Montpetit
Researchers at Mayo Clinic recently found that a specific pair of proteins may be a successful prognostic biomarker for identifying smoking-related lung cancers. The clinical significance of neuroendocrine (NE) differentiation in lung adenocarcinoma (AD), and the most appropriate biomarkers for this assessment, has long been debated. In the absence of a gold standard, investigators have most […]
Tags: biomarker, biomarkers, cancer, center for individualized medicine, George Vasmatzis, Lung Cancer, Personal Care, Personal Medicine, personalized care, personalized medicine, Smoke, Smoker